← Leaderboards
Chau-Ching Liu
University Of Pittsburgh At Pittsburgh
$1,181,862
Attributed
$1,181,862
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $340.9K · FY2008–11$500K$375K$250K$125K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$1,181,862 · 1
By mechanism
R01$1,181,862 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Susan Manzi$6,430,165
- M. Ilyas Kamboh$33,365,358
- Carol Marie Greco$9,223,496
- Dario Aa Vignali$40,087,127
- Sarah L. Gaffen$22,116,009
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteComplement ActivationAntigen-Antibody ComplexAntigen TargetingActivation ProductAutoantigensAutoimmune DiseasesBaseBinding (Molecular Function)BiochemicalAutoantibodiesAntibodiesBlood CellsBlood PlateletsBody SystemCell PhysiologyCellsCell SurfaceChronicClinically RelevantClinical PhenotypeClinical TrialsComplementComplement C4d
Grant awards (4)
Lymphocyte-Bound Complement Activation Products: Clues to SLE Pathogenesis$324,169
R01 · FY2011 · AI · contact PI
Lymphocyte-Bound Complement Activation Products: Clues to SLE Pathogenesis$327,443
R01 · FY2010 · AI · contact PI
Lymphocyte-Bound Complement Activation Products: Clues to SLE Pathogenesis$340,875
R01 · FY2009 · AI · contact PI
Lymphocyte-Bound Complement Activation Products: Clues to SLE Pathogenesis$189,375
R01 · FY2008 · AI · contact PI